Cellebrite DI Ltd. Condensed and Consolidated - US GAAP Income Statements
(U.S. Dollars in thousands, except share and per share data - unaudited)
Yr Ended 31-Dec |
$ 271,028 82,007 353,035 17,285 30,883 |
401,203 |
26,004 -16,200 20,389 |
62,593 |
338,610 98,415 132,389 50,900 - |
281,704 |
56,906 (332,890) |
(275,984) 7,023 |
$ (283,007) |
$ (1.35) $ (1.35) 209,471,827 209,471,827 84.4% 24.5% 33.0% 12.7% 70.2% 14.2% -2.5% -70.5% |
FY 2023 FY 2024
FY 2025
Yr Ended 31-Dec |
$ 330,765 96,245 427,010 17,771 30,894 |
475,675 |
37,461 87 15,617 22,007 |
75,172 |
400,503 113,877 154,814 65,332 - |
334,023 |
66,480 24,198 |
90,678 12,352 |
$ 78,326 |
$ 0.32 $ 0.31 241,626,316 249,903,126 84.2% 23.9% 32.5% 13.7% 70.2% 14.0% 13.6% 16.5% |
Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec
FY 2026
YTD 30-Sep |
$ 295,397 76,851 372,248 14,005 22,208 |
408,461 |
- 43,017 3,490 13,450 15,645 |
75,602 |
-332,859 108,220 123,806 57,890 - |
289,916 |
42,943 13,619 |
56,562 12,597 |
$ 43,965 |
$ 0.18 $ 0.17 247,865,510 253,087,365 81.5% 26.5% 30.3% 14.2% 71.0% 10.5% 22.3% 10.8% |
Quarter Ended 31-Mar 30-Jun 30-Sep
Revenue:
Subscription services
$ 76,688 $
80,814
$ 84,195 $
89,068
$ 96,549
$ 97,685
$ 101,163
Term-license Total subscription
Other non-recurring*
Professional services
Total revenue
Cost of revenue: Subscription services Term-license
Other non-recurring* Professional services
Total cost of revenue
Gross profit
Operating expenses: Research and development Sales and marketing General and administrative Other
Total operating expenses Operating income (loss) Financial income (expense), net
Income (loss) before taxes on income
Tax expense (income)
19,141 22,147 28,531 26,426
95,829 102,961 112,726 115,494
4,411 3,292 5,504 4,564
7,309 7,023 7,799 8,763
107,549 113,276 126,029 128,821
8,432 8,522 10,005 10,502
- - - 87
3,301 3,198 4,791 4,327
5,757 5,957 5,518 4,775
17,490 17,677 20,314 19,691
90,059 95,599 105,715 109,130
27,277 28,611 28,124 29,865
38,768 38,685 38,800 38,561
11,746 13,886 19,801 19,899
- - - -
77,791 81,182 86,725 88,325
12,268 14,417 18,990 20,805
7,060 6,374 5,298 5,466
19,328 20,791 24,288 26,271
1,928 1,315 4,099 5,010
21,304 21,805 33,742
117,853 119,490 134,905
3,668 3,912 6,425
6,780 7,736 7,692
128,301 131,138 149,022
- - -
13,439 14,627 14,951
799 1,354 1,337
3,497 3,764 6,189
4,685 5,462 5,498
22,420 25,207 27,975
105,881 105,931 121,047
35,872 35,961 36,387
43,222 43,753 36,831
17,668 19,268 20,954
- - -
96,762 98,982 94,172
9,119 6,949 26,875
4,515 4,238 4,866
13,634 11,187 31,741
2,696 4,816 5,085
Net Income (loss)
Basic net earnings (loss) per share Diluted net earnings (loss) per share
$ 17,400
$ 0.07
$ 0.07
$ 19,476
$ 0.08
$ 0.08
$ 20,189
$ 0.08
$ 0.08
$ 21,261
$ 0.09
$ 0.08
$ 10,938
$ 0.04
$ 0.04
$ 6,371
$ 0.03
$ 0.02
$ 26,656
$ 0.11
$ 0.10
Yr Ended 31-Dec |
$ 209,751 70,663 280,414 13,561 31,135 |
325,110 |
19,219 6 13,766 20,240 |
53,231 |
271,879 84,386 110,813 43,443 - |
238,642 |
33,237 (108,800) |
(75,563) 5,537 |
$ (81,100) |
$ (0.42) $ (0.43) 190,154,549 190,154,549 83.6% 26.0% 34.1% 13.4% 73.4% 10.2% -7.3% -24.9% |
Pro-forma weighted average number of shares used to compute basic net earnings per share Pro-forma weighted average number of shares used to compute diluted net earnings per share
Gross margin
R&D % of total revenue S&M % of total revenue G&A % of total revenue
Total Operating Expenses % of total revenues
Operating margin Tax rate
Net margin
Note: This document should be read in conjunction with the Company's SEC Filings.
*Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and was previously referred
237,246,654 240,358,573 243,508,803 245,282,244
249,302,220 248,980,462 249,719,713 251,501,118
83.7% 84.4% 83.9% 84.7%
25.4% 25.3% 22.3% 23.2%
36.0% 34.2% 30.8% 29.9%
10.9% 12.3% 15.7% 15.4%
72.3% 71.7% 68.8% 68.6%
11.4% 12.7% 15.1% 16.2%
10.0% 6.3% 16.9% 19.1%
16.2% 17.2% 16.0% 16.5%
246,470,084 247,617,591 249,475,824
252,077,487 252,788,652 254,362,925
82.5% 80.8% 81.2%
28.0% 27.4% 24.4%
33.7% 33.4% 24.7%
13.8% 14.7% 14.1%
75.4% 75.5% 63.2%
7.1% 5.3% 18.0%
19.8% 43.0% 16.0%
8.5% 4.9% 17.9%
FY 2026
Quarter Ended
Quarter Ended
31-Mar 30-Jun 30-Sep 31-Dec 31-Mar 30-Jun 30-Sep
$ 76,688
19,141
95,829
4,411
$ 80,814 $ 84,195
22,147 28,531
102,961 112,726
3,292 5,504
$ 89,068
26,426
115,494
4,564
$
96,549
$
97,685
7,309 7,023 7,799 8,763
107,549 113,276 126,029 128,821
21,304
117,853
3,668
6,780
128,301
$ 101,163
21,805 33,742
119,490 134,905
3,912 6,425
7,736 7,692
131,138 149,022
8,113
-3,044
8,143
-2,943
9,361
-5,095
9,115
87
4,243
5,583 5,764 5,030 4,590
16,740 16,850 19,486 18,035
9,438
799
3,423
4,456
18,116
8,738 8,630
1,354 1,337
3,690 6,098
5,231 5,267
19,013 21,332
90,809
96,426
106,543
110,786
110,185
112,125
127,690
24,198
35,694
25,388
35,281
24,762
35,136
25,800
34,638
8,946 9,533 10,675 13,850
68,838 70,202 70,573 74,288 21,971 26,224 35,970 36,498
7,060 6,374 5,298 5,466
29,031 32,598 41,268 41,964
1,928 1,315 4,099 5,010
(924) (510) (309) (260)
- - - -
- - - -
$ 26,179 $ 30,773 $ 36,860 $ 36,694
29,826
39,569
12,204
81,599
28,586
4,515
33,101
2,696
215
-
-
$ 30,620
29,446 29,960
39,955 33,094
12,919 13,106
82,320 76,160 29,805 51,530
4,238 4,866
34,043 56,396
4,816 5,085
465 (5,761)
- -
- -
$ 29,692 $ 45,550
FY 2025
FY 2024
FY 2023
Yr Ended 31-Dec |
$ 209,751 70,663 280,414 13,561 31,135 |
325,110 |
19,219 6 13,644 18,577 |
51,446 |
273,664 77,866 102,842 37,674 |
218,382 |
55,282 (108,800) |
(53,518) 5,537 633 -119,348 $ 60,926 |
$ 0.31 $ 0.28 190,154,549 206,194,081 84.2% 24.0% 31.6% 11.6% 67.2% 17.0% -9.2% 18.7% |
Yr Ended 31-Dec |
$ 271,028 82,007 353,035 17,285 30,883 |
401,203 |
26,004 -16,047 18,313 |
60,364 |
340,839 88,648 121,752 38,320 |
248,720 |
92,119 (332,890) |
(240,771) 7,023 (4,049) -349,604 $ 97,761 |
$ 0.45 $ 0.42 209,471,827 227,258,731 85.0% 22.1% 30.3% 9.6% 62.0% 23.0% -1.2% 24.4% |
Yr Ended 31-Dec |
$ 330,765 96,245 427,010 17,771 30,894 |
475,675 |
34,732 87 15,325 20,967 |
71,111 |
404,564 100,148 140,749 43,004 |
283,901 |
120,663 24,198 |
144,861 12,352 (2,003) - - $ 130,506 |
$ 0.54 $ 0.51 241,626,316 254,677,860 85.1% 21.1% 29.6% 9.0% 59.7% 25.4% 7.1% 27.4% |
YTD 30-Sep |
$ 295,397 76,851 372,248 14,005 22,208 |
408,461 |
26,806 3,490 13,211 14,954 |
58,461 |
350,000 89,232 112,618 38,229 |
240,079 |
109,921 13,619 |
123,540 12,597 (5,081) - - $ 105,862 |
$ 0.42 $ 0.40 247,865,510 259,774,704 85.7% 21.8% 27.6% 9.4% 58.8% 26.9% 6.1% 25.9% |
Cellebrite DI Ltd. Condensed and Consolidated - Non-GAAP Income Statements
(U.S. Dollars in thousands, except share and per share data - unaudited)
Revenue:
Subscription services Term-license
Total subscription Other non-recurring* Professional services
Total revenue
Cost of revenue: Subscription services Term-license
Other non-recurring* Professional services
Total cost of revenue
Gross profit
Operating expenses: Research and development Sales and marketing General and administrative
Total operating expenses Non-GAAP operating income Financial Income, net
Income (loss) before taxes on income
Tax expense (income) Income tax adjustment One time tax income Finance expense (income) Non-GAAP net income
Basic net earnings (loss) per share Diluted net earnings per share
$ 0.11 $
$ 0.10 $
0.13 $
0.12 $
0.15 $
0.14 $
0.15
0.14
$ 0.12 $
$ 0.12 $
0.12 $
0.11 $
0.18
0.17
Pro-forma weighted average number of shares used to compute basic net earnings per share Pro-forma weighted average number of shares used to compute diluted net earnings per share
Gross margin
R&D % of total revenue S&M % of total revenue G&A % of total revenue
Total Operating Expenses % of total revenues
Operating margin Tax rate
Net margin
Note: This document should be read in conjunction with the Company's SEC Filings.
237,246,654 240,358,573 243,508,803 245,282,244
252,456,562 252,713,944 256,157,437 257,274,507
84.4% 85.1% 84.5% 86.0%
22.5% 22.4% 19.6% 20.0%
33.2% 31.1% 27.9% 26.9%
8.3% 8.4% 8.5% 10.8%
64.0% 62.0% 56.0% 57.7%
20.4% 23.2% 28.5% 28.3%
3.5% 2.5% 9.2% 11.3%
24.3% 27.2% 29.2% 28.5%
246,470,084 247,617,591 249,475,824
259,252,345 259,522,205 260,516,532
85.9% 85.5% 85.7%
23.2% 22.5% 20.1%
30.8% 30.5% 22.2%
9.5% 9.9% 8.8%
63.6% 62.8% 51.1%
22.3% 22.7% 34.6%
8.8% 15.5% -1.2%
23.9% 22.6% 30.6%
*Other non-recurring revenue is composed of hardware sales, usage fees and perpetual licenses, and was previously referred to "Perpetual license and other." Changing the name for this type of revenue reflects that perpetual license revenue has declined to relatively insignificant levels with hardware sales now representing the majority of this type of revenue.
FY 2025
FY 2024
FY 2023
Cellebrite DI Ltd. Condensed and Consolidated - Balance Sheets
(U.S. Dollars in thousands)
ASSETS
Current Assets
Quarter Ended
31-Mar 30-Jun 30-Sep
Quarter Ended
FY 2026
Yr Ended 31-Dec |
$ 124,457 161,049 151,544 104,972 19,630 6,595 7,603 |
575,850 |
14,618 97,959 10,880 22,209 81,469 16,308 119,559 |
363,002 |
$ 938,852 |
$ 16,834 71,244 277,583 3,996 |
369,657 |
16,677 49,526 - - -18,674 |
84,877 |
$ 454,534 |
* -568,721 (85) 2,220 (86,538) |
484,318 |
938,852 |
31-Mar 30-Jun 30-Sep
Cash and cash equivalents
$ 90,475
$ 179,223
$ 281,361
$ 133,689
$ 141,250
$ 223,055
Short-term deposits Marketable securities Trade receivables
Prepaid expenses and other current assets Contract acquisition costs
Inventories
Total current assets
Non-current assets Other non-current assets Marketable securities Deferred tax assets, net
Property and equipment, net Intangible assets, net
Operating lease right-of-use assets, net Goodwill
Total non-current assets
177,754 146,053 127,216
141,257 146,908 117,135
81,142 93,127 104,196
17,625 23,489 20,812
6,260 7,772 9,034
8,969 9,537 8,648
523,482 606,109 668,402
6,897 6,687 6,289
100,305 85,661 69,580
11,545 12,586 12,727
17,766 19,962 22,533
10,922 10,242 9,807
10,261 17,464 16,267
28,714 28,714 28,714
186,410 181,316 165,917
140,777 146,759 121,207
154,602 154,522 139,607
72,739 110,782 139,816
25,799 21,514 21,375
5,732 6,466 5,844
7,528 8,388 7,509
540,866 589,681 658,413
7,091 7,344 7,803
105,491 103,185 109,410
11,760 11,667 11,791
23,150 24,552 27,431
127,966 121,909 117,928
16,403 16,414 16,151
119,559 119,559 119,559
411,420 404,630 410,073
Total Assets
Liabilities, redeemable convertible preferred shares and shareholders' equity (deficiency)
Current Liabilities
Trade payables
$ 709,892
$ 10,214
$ 787,425
$ 10,587
$ 834,319
$ 11,136
$ 952,286
$ 10,868
$ 994,311
$ 18,113
$ 1,068,486
$ 20,473
Other accounts payable and accrued expenses Deferred revenues
Operating lease liabilities
Total current liabilities
Long-term Liabilities
Other long-term liabilities Long-term deferred revenues
Restricted Sponsor Shares liability Price Adjustment Shares liability Derivative warrant liabilities Operating lease liabilities
Total long-term liabilities
53,932 67,969 62,486
219,442 227,177 239,677
4,210 4,236 3,618
287,798 309,969 316,917
6,566 6,852 7,510
45,641 44,096 44,386
- - -
- - -
- - -
6,393 18,095 17,821
58,600 69,043 69,717
79,652 77,009 73,351
255,095 263,350 295,513
4,596 5,736 6,115
350,211 364,208 395,452
23,179 24,573 25,424
50,147 49,940 51,065
- - -
- - -
- - -
18,209 17,493 17,238
91,535 92,006 93,727
Total Liabilities
Yr Ended 31-Dec |
$ 191,659 153,746 101,818 82,358 23,246 5,827 8,939 |
567,593 |
7,682 36,601 11,072 16,995 11,306 10,604 28,714 |
122,974 |
$ 690,567 |
$ 11,077 63,330 216,970 4,125 |
295,502 |
6,954 45,247 - - -6,844 |
59,045 |
$ 354,547 |
* -498,883 (85) 2,086 (164,864) |
336,020 |
$ 690,567 |
$ 346,398
$ 379,012
$ 386,634
$ 441,746
$ 456,214
$ 489,179
Shareholders' equity (deficiency)
Share capital
Additional paid-in capital
Treasury stock, NIS 0.00001 par value; 41,776 ordinary shares Accumulated other comprehensive income
(Accumulated deficit) Retained earnings Total shareholders' equity (deficiency)
* - * - * -
510,153 533,847 553,111
(85) (85) (85)
890 2,639 2,459
(147,464) (127,988) (107,800)
363,494 408,413 447,685
* - * - * -
585,233 605,809 622,769
(85) (85) (85)
992 1,602 (804)
(75,600) (69,229) (42,573)
510,540 538,097 579,307
Yr Ended 31-Dec |
$ 189,517 74,713 38,693 77,269 26,400 5,550 9,940 |
422,082 |
7,341 28,859 7,024 15,896 10,594 14,260 26,829 |
83,974 |
$ 506,056 |
$ 8,282 44,845 195,725 4,972 |
253,824 |
5,515 47,098 47,247 81,715 54,117 9,157 |
244,849 |
$ 498,673 |
* -(84,896) (85) 1,050 118,143 |
34,212 |
$ 532,885 |
Total liabilities, redeemable convertible preferred shares and shareho
* Less than US$ 1.
Note: This document should be read in conjunction with the Company's SEC Filings.
$ 709,892
$ 787,425
$ 834,319
$ 952,286
$ 994,311
$ 1,068,486
Yr Ended 31-Dec |
$ (81,100) 18,998 (1,106) 10,011 -(7,737) 5,125 34,102 29,715 55,531 2,271 46,114 (5,610) (9,211) 4,362 (4,196) -243 3,691 734 121 |
102,058 |
(5,231) (2,687) (55,317) 56,336 - -(15,641) |
(22,540) |
-19,142 2,623 |
21,765 |
101,283 589 87,645 |
$189,517 |
$ 10,047 $ - $ - $ 4,363 $ - $ - $ - |
Yr Ended 31-Dec |
$(283,007) 30,575 (2,904) 10,607 -(10,736) (4,015) 110,664 65,889 173,051 (5,829) 22,317 (341) 3,201 5,335 (4,839) -982 2,755 17,586 880 |
132,171 |
(8,566) (2,043) (127,789) 59,971 -(2,748) (68,298) |
(149,473) |
42 17,265 3,344 |
20,651 |
3,349 (1,207) 189,517 |
$ 191,659 |
$ 7,706 $ - $ - $ 1,884 $ 164,770 $ 113,136 $ 254,766 |
Yr Ended 31-Dec |
$ 78,326 44,892 (2,371) 11,867 554 (8,164) 75 - - -(15,781) 49,768 (6,936) 5,614 4,585 547 1,760 1,632 4,943 4,248 (2,015) |
173,544 |
(13,225) -(321,231) 152,992 59,809 (147,456) 861 |
(268,250) |
-20,097 4,956 |
25,053 |
(69,653) 2,451 191,659 |
$ 124,457 |
$ (549) $ - $ - $ 11,154 $ - $ - $ - |
FY 2023 FY 2024 FY 2025 FY 2026
Cellebrite DI Ltd. Condensed and Consolidated - Quarterly US GAAP Cash Flows
(U.S. Dollars in thousands - unaudited)
Quarter Ended
31-Mar 30-Jun 30-Sep 31-Dec
Quarter Ended
YTD 30-Sep |
$ 43,965 45,079 (2,117) 25,259 0 (5,373) (695) - - -(34,761) 20,527 (160) 197 3,313 (2,473) -163 3,467 (4,858) 2,522 |
94,055 |
(10,893) (24,089) (195,451) 90,222 105,342 (15,278) 45,215 |
(4,932) |
-5,569 4,168 |
9,737 |
98,860 (262) 124,457 |
$223,055 |
$ 15,157 $ - $ - $ 3,156 $ - $ - $ - |
31-Mar 30-Jun 30-Sep
Cash flows from operating activities:
Net income (loss)
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
$ 17,400 $
19,476
$ 20,189 $
21,261
$ 10,938
$ 6,371
$ 26,656
Share-based compensation and RSU's
Amortization of premium and discount and accrued interest on marketable securities Depreciation and amortization
Disposal and write-off of property and equipment Interest income from short-term deposits Deferred tax assets, net
Revaluation of derivative warrants
Remeasurement of Restricted Sponsor Shares liability Remeasurement of Price Adjustment Shares liability (Increase) decrease in trade receivables
Increase (decrease) in deferred revenue Decrease (increase) in other non-current assets
Decrease (Increase) in prepaid expenses and other current assets Changes in operating lease assets
Changes in operating lease liability
Abandonment of right-of-use assets and disposal of leasehold Improvements (Increase) decrease in inventories
(Decrease) increase in trade payables
Increase (decrease) in other accounts payable and accrued expenses (Decrease) increase in other long-term liabilities
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Capital expenditures Purchase of intangible assets
Investment in marketable securities
Proceeds from maturities of marketable securities Proceeds from sales of marketable securities
Payment related to business combination, net of cash acquired
Short-term deposits, net
Net cash (used in) provided by investing activities
Cash flows from financing activities:
Exercise of warrants, net Exercise of options to shares Proceeds from ESPP, net
Net cash provided by financing activities
Net (decrease) increase in cash and cash equivalents and restricted cash
Net effect of currency translation on cash and cash equivalents
Cash and cash equivalents and restricted cash at beginning of period
8,777 8,810 15,308 11,997
(523) (1,202) (488) (158)
2,631 2,592 2,703 3,941
- - - 554
(2,380) (2,303) (1,734) (1,747)
(386) (1,387) (51) 1,899
- - - -
- - - -
- - - -
1,721 (10,931) (11,225) 4,654
992 2,310 13,310 33,156
785 210 398 (8,329)
5,480 (2,748) 336 2,546
1,156 1,070 1,197 1,162
(1,179) (532) (892) 3,150
- - - 1,760
(10) (524) 882 1,284
(1,046) (166) 713 5,442
(12,152) 17,622 (8,032) 6,810
(388) 286 658 (2,571)
20,878 32,583 33,272 86,811
(2,339) (3,608) (3,322) (3,956)
- - - -(129,956) (53,190) (12,057) (126,028)
27,419 32,204 58,597 34,772
- 31,166 - 28,643
- - - (147,456) (21,628) 34,005 20,570 (32,086)
(126,504) 40,577 63,788 (246,111)
- - - -
2,493 12,624 3,958 1,022
1,127 1,202 1,309 1,318
3,620 13,826 5,267 2,340
(102,006) 86,986 102,327 (156,960)
822 1,762 (189) 56
191,659 90,475 179,223 281,361
14,384 15,249 15,446
(1,148) (237) (732)
7,005 8,915 9,339
- - -
(1,793) (1,736) (1,844)
(750) (15) 70
- - -
- - -
- - -
32,441 (38,070) (29,132)
(20,861) 7,987 33,401
552 (253) (459)
(4,964) 4,351 810
1,055 1,058 1,200
(1,015) (645) (813)
- - 0
144 (859) 878
(5,987) 7,181 2,273
(10,393) 6,898 (1,363)
277 1,394 851
19,885 17,589 56,581
(3,041) (3,068) (4,784)
(7,059) (8,560) -8,470
(74,575) (50,050) (70,826)
24,607 36,338 29,277
39,706 15,840 49,796
(15,278) 0 0
22,065 (4,246) 27,396
(13,575) (13,746) 22,389
- - -
2,128 2,123 1,318
1,383 1,485 1,300
3,511 3,608 2,618
9,821 7,451 81,588
(589) 110 217
124,457 133,689 141,250
Cash and cash equivalents and restricted cash at end of period
$ 90,475 $
179,223
$ 281,361
$ 124,457
$133,689
$ 141,250
$223,055
Supplemental cash flow information:
Income taxes (received) paid
Purchase of property and equipment on suppliers' credit Purchase of intangible assets
Operating lease liabilities arising from obtaining right of use assets Reclassification of warrants from liability to equity
Reclassification of Restricted Sponsor Shares from liability to equity
Reclassification of Price Adjustment Shares from liability to equity
Note: This document should be read in conjunction with the Company's SEC Filings.
$ 806 $
$ - $
$ - $
$ 813 $
$ - $
$ - $
$ - $
(8,879) $
- $
- $
12,328 $
- $
- $
- $
4,686 $
- $
- $
- $
- $
- $
- $
2,838
-
-(1,987)
-
-
-
$ 3,538
$ -
$ -
$ 1,150
$ -
$ -
$ -
$ 6,997
$ -
$ -
$ 1,069
$ -
$ -
$ -
$ 4,622
$ -
$ -
$ 937
$ -
$ -
$ -
FY 2026
FY 2025
FY 2024
FY 2023
Yr Ended 31-Dec |
$ 53,231 1,733 -52 $ 51,446 |
$ 271,879 1,733 -52 |
$ 273,664 |
$ 238,642 -(345) 17,265 3,347 (7) |
$ 218,382 |
Yr Ended 31-Dec |
$ 62,593 2,227 - 2 $ 60,364 |
$ 338,610 2,227 - 2 |
$ 340,839 |
$ 281,704 1,068 -28,348 3,349 219 |
$ 248,720 |
Yr Ended 31-Dec |
$ 75,172 3,180 881 - $ 71,111 |
$ 400,503 3,180 881 - |
$ 404,564 |
$ 334,023 574 -41,712 4,018 3,818 |
$ 283,901 |
YTD 30-Sep |
$ 75,602 2,047 15,093 1 $ 58,461 |
$ 332,859 2,047 15,093 1 |
$ 350,000 |
$ 289,916 520 -43,032 4,055 2,230 |
$ 240,079 |
Quarter Ended 31-Mar 30-Jun 30-Sep 31-Dec $ 17,490 $ 17,677 $ 20,314 $ 19,691 750 827 828 775 - - - 881 - - - - $ 16,740 $ 16,850 $ 19,486 $ 18,035 | Quarter Ended 31-Mar 30-Jun 30-Sep $ 22,420 $ 25,207 $ 27,975 692 657 698 3,612 5,536 5,945 - 1 - $ 18,116 $ 19,013 $ 21,332 | ||||||||||||||
$ 90,059 | $ 95,599 | $ 105,715 | $ 109,130 | $ 105,881 | $ 105,931 | $ 121,047 | |||||||||
750 | 827 | 828 | 775 | 692 | 657 | 698 | |||||||||
- | - | - | 881 | 3,612 | 5,536 | 5,945 | |||||||||
- | - | - | - | - | 1 | - | |||||||||
$ 90,809 | $ 96,426 | $ 106,543 | $ 110,786 | $ 110,185 | $ 112,125 | $ 127,690 | |||||||||
$ 77,791 | $ 81,182 | $ 86,725 | $ 88,325 | $ 96,762 | $ 98,982 | $ 94,172 | |||||||||
- | - | 574 | - | - | - | 520 | |||||||||
- | - | - | - | - | - | - | |||||||||
8,027 | 7,983 | 14,480 | 11,222 | 13,692 | 14,592 | 14,748 | |||||||||
926 | 931 | 934 | 1,227 | 1,362 | 1,394 | 1,299 | |||||||||
- | 2,066 | 164 | 1,588 | 109 | 676 | 1,445 | |||||||||
$ 68,838 | $ 70,202 | $ 70,573 | $ 74,288 | $ | 81,599 | $ | 82,320 | $ | 76,160 | ||||||
(U.S. Dollars in thousands, except share and per share data)
GAAP cost of revenue: Cost of revenue Less:
Share-based compensation expense Amortization of intangible assets Acquisition-related costs
Non-GAAP cost of revenueGAAP gross profit:
Gross profit
Share-based compensation expense Amortization of intangible assets Acquisition-related costs
Non-GAAP gross profitGAAP operating expenses: Operating expenses Less:
Executive severance costs Issuance expenses
Share-based compensation expense Amortization of intangible assets Acquisition-related costs
Non-GAAP operating expensesFY 2026
Quarter Ended
31-Mar
30-Jun
30-Sep
31-Dec
31-Mar
Quarter Ended
30-Jun
30-Sep
$ 12,268
-
-8,777
926
-
$ 21,971
$ 14,417 $ 18,990
- 574
- -
8,810 15,308
931 934
2,066 164
$ 26,224 $ 35,970
$ 20,805
-
-11,997
2,108
1,588
$ 36,498
$
$
9,119
-
-14,384
4,974
109
28,586
$
$
6,949
-
-15,249
6,930
677
29,805
$
$
26,875
520
-15,446
7,244
1,445
51,530
$ 17,400
-
-
-
-8,777
926
-(924)
-
$ 26,179
$ 19,476 $ 20,189
- 574
- -
- -
- -
8,810 15,308
931 934
2,066 164
(510) (309)
- -
$ 30,773 $ 36,860
$ 21,261
-
-
-
-11,997
2,108
1,588
(260)
-
$ 36,694
$
$
10,938
-
-
-
-14,384
4,974
109
215
-
30,620
$
$
6,371
-
-
-
-15,249
6,930
677
465
-
29,692
$
$
26,656
520
-
-
-15,446
7,244
1,445
-5,761
-
45,550
$ 17,400
(7,060)
1,928
2,631
-
-8,777
-
$ 23,676
22.0%
$ 19,476 $ 20,189
(6,374) (5,298)
1,315 4,099
2,592 2,703
- 574
- -
8,810 15,308
2,066 164
$ 27,885 $ 37,739
24.6% 29.9%
$ 21,261
(5,466)
5,010
3,941
-
-11,997
1,588
$ 38,331
29.8%
$
$
10,938
(4,515)
2,696
7,005
-
-14,384
109
30,617
23.9%
$
$
6,371
(4,238)
4,816
8,915
-
-15,249
677
31,790
24.2%
$
$
26,656
(4,866)
5,085
9,339
520
-15,446
1,445
53,625
36.0%
20,878
32,583
33,272
86,811
19,885
17,589
56,581
(2,339)
$18,539
(3,608) (3,322) (3,956)
$28,975 $ 29,950 $ 82,855
$
(3,041)
16,844
$
(3,068)
14,521
$
(4,784)
51,797
FY 2025
FY 2024
FY 2023
Yr Ended 31-Dec |
$ 33,237 -(345) 18,998 3,347 45 |
$ 55,282 |
$ (81,100) - -(345) -18,998 3,347 45 633 119,348 |
$ 60,926 |
$ (81,100) 108,800 5,537 10,011 -(345) 18,998 45 |
$ 61,946 |
19.1% 102,058 (5,231) |
$ 96,827 |
29.8% |
Yr Ended 31-Dec |
$ 56,906 1,068 -30,575 3,349 221 |
$ 92,119 |
$ (283,007) 1,068 - - -30,575 3,349 221 (4,049) 349,604 |
$ 97,761 |
$ (283,007) 332,890 7,023 10,607 1,068 -30,575 221 |
$ 99,377 |
24.8% 132,171 (8,566) |
$ 123,605 |
30.8% |
Yr Ended 31-Dec |
$ 66,480 574 -44,892 4,899 3,818 |
$ 120,663 |
$ 78,326 574 - - -44,892 4,899 3,818 (2,003) - |
$ 130,506 |
$ 78,326 (24,198) 12,352 11,867 574 -44,892 3,818 |
$ 127,631 |
26.8% 173,544 (13,225) |
$ 160,319 |
33.7% |
YTD 30-Sep |
$ 42,943 520 -45,079 19,148 2,231 |
$ 109,921 |
$ 43,965 520 - - -45,079 19,148 2,231 -5,081 - |
$ 105,862 |
$ 43,965 (13,619) 12,597 25,259 520 -45,079 2,231 |
$ 116,032 |
28.4% 94,055 (10,893) |
$ 83,162 |
20.4% |
(U.S. Dollars in thousands, except share and per share data)
GAAP operating income (loss) Executive severance costs Issuance expenses
Share-based compensation expense Amortization of intangible assets Acquisition-related costs
Non-GAAP operating income (loss)GAAP net income (loss) Executive severance costs One-time tax income Issuance expenses
Dividend participation compensation Share-based compensation expense Amortization of intangible assets Acquisition related costs
Income tax expense Finance expenses (income)
Non-GAAP net income (loss)GAAP net income (loss) Financial (Income) expense Tax expense (income)
Depreciation and amortization Executive severance costs Issuance expenses
Share-based compensation expense Acquisition-related costs
Adjusted EBITDAAdjusted EBITDA margin
Cash flows from operating activitiesLess:
Capital expenditures
Free Cash FlowFree Cash Flow margin
Note: This document should be read in conjunction with the Company's SEC Filings.
17.2% 25.6% 23.8% 64.3%
13.1% 11.1% 34.8%
FY 2026
Quarter Ended
31-Mar
30-Jun
30-Sep
31-Dec
31-Mar
Quarter Ended
30-Jun
30-Sep
FY 2025
FY 2024
FY 2023
Yr Ended 31-Dec |
$ 172,154 112,247 40,709 |
$ 325,110 53.0% 34.5% 12.5% |
100.0% 315,689 - 315,689 315,689 165,389 114,206 36,094 125% |
Yr Ended 31-Dec |
$ 215,531 134,921 50,751 |
$ 401,203 53.7% 33.6% 12.6% |
100.0% 395,899 -395,899 395,899 214,565 134,061 47,273 124% |
Yr Ended 31-Dec |
$ 256,582 161,361 57,732 |
$ 475,675 53.9% 33.9% 12.0% |
100.0% 480,760 16,078 464,682 480,760 256,380 166,440 57,940 116% |
YTD 30-Sep |
$ 216,562 137,948 53,951 |
$ 408,461 - 53.0% 33.8% 13.2% |
100.0% 528,452 - 528,452 528,452 280,400 179,651 68,401 116% |
Cellebrite DI Ltd. - Revenue Mix
(U.S. Dollars in thousands - unaudited)
Revenue by geography:
Americas
$ 56,531
$ 61,246
$ 72,805
$ 66,000
$ 66,006
$ 69,249
$ 81,307
EMEA APAC
37,421 38,461 38,488 46,991
13,597 13,569 14,736 15,830
46,825 43,300 47,823
15,470 18,589 19,892
Total revenue
$ 107,549
$ 113,276
$ 126,029
$ 128,821
$ 128,301
$ 131,138
$ 149,022
Revenue % of total:
Americas EMEA APAC
Total revenue
Annual recurring revenue (in thousands)
Total ARR
ARR related to acquisitions Organic ARR
Annual recurring revenue (in thousands)
America EMEA APAC
Recurring revenue net dollar-based retention rate
Note: This document should be read in conjunction with the Company's SEC Filings.
52.6% 54.0% 57.8% 51.2%
34.8% 34.0% 30.5% 36.5%
12.6% 12.0% 11.7% 12.3%
100.0% 100.0% 100.0% 100.0%
408,060 418,875 439,803 480,760
- - - 16,078 408,060 418,875 439,803 464,682
408,060 418,875 439,803 480,760
221,259 226,296 240,244 256,380
136,432 141,762 147,200 166,440
50,369 50,817 52,359 57,940
121% 120% 117% 116%
51.4% 52.8% 54.6%
36.5% 33.0% 32.1%
12.1% 14.2% 13.3%
100.0% 100.0% 100.0%
492,970 507,771 528,452
- - -
492,970 507,771 528,452
492,970 507,771 528,452
261,090 267,414 280,400
170,930 175,072 179,651
60,950 65,285 68,401
115% 117% 116%
